Combination hormonal therapy tamoxifen fluoxymesterone versus tamoxifen postmenopausal women metastatic breast cancer updated analysis randomized trial therapy tamoxifen TAM fluoxymesterone FLU efficacious TAM postmenopausal women metastatic breast cancer Patients TAM FLU dose drugs mg twice Objective responses patients TAM FLU patients two-sided Time progression TAM FLU medians months Cox model Duration response survival similar treatment arms patients estrogen receptor ER years age significant advantages treatment TAM FLU response rate time progression particular note patient group TAM FLU survival advantage Cox model data confirmation prospective trial substantive therapeutic advantage TAM FLU TAM elderly women ER fmol 